Clinical Trial Update: Chronicling the COPD Patient Journey and Change in COPD Symptoms, Quality of Life and Exacerbations Following Initiation of Budenoside/Glycopyrronium/Formoterol [BGF]

View source ↗

Summary

ClinicalTrials.gov entry describing a COPD study evaluating changes in symptoms, quality of life, and exacerbations after initiation of budesonide/glycopyrroniu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Budesonide/Glycopyrronium/Formoterol (budesonide/glycopyrronium/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Status: ACTIVE_NOT_RECRUITING